Table 2.
Prevalence of PIP among the whole cohort and by subgroups
| Group | No. of persons with a PIP (STOPP criterion as the first PIP) | No. of persons eligible for the study cohort | Prevalence (STOPP criterion only) (%) |
|---|---|---|---|
| Whole cohort (STOPP criterion only) | 1,581,897 (907,993) | 2,256,163 | 70.1 (40.2) |
| Sex | |||
| Female | 876,808 (546,190) | 1,244,562 | 70.5 (43.9) |
| Male | 705,089 (361,803) | 1,011,601 | 69.7 (35.8) |
| Median age during cohort participation, years | |||
| 66–70 | 529,532 (377,006) | 929,009 | 57.0 (40.6) |
| 71–75 | 393,177 (218,908) | 529,320 | 74.3 (41.4) |
| 76–80 | 283,494 (138,957) | 350,753 | 80.8 (39.6) |
| 81–85 | 215,660 (100,369) | 256,025 | 84.2 (39.2) |
| 86–90 | 112,228 (51,125) | 132,145 | 84.1 (38.7) |
| > 90 | 47,806 (21,628) | 58,911 | 81.2 (36.7) |
PIP potentially inappropriate prescription, STOPP Screening Tool of Older People’s Prescriptions